Biomedical Engineering Blog

Biomedical Engineering

The Biomedical Engineering blog is the place for conversation and discussion about topics related to engineering principles of the medical field. Here, you'll find everything from discussions about emerging medical technologies to advances in medical research. The blog's owner, Chelsey H, is a graduate of Rensselaer Polytechnic Institute (RPI) with a degree in Biomedical Engineering.

Previous in Blog: Another Good Reason to Drink Red Wine   Next in Blog: Success In Regrowing Muscles From Pig Cells
Close
Close
Close
2 comments
Rate Comments: Nested

Blood Protein from Rice

Posted November 10, 2011 10:46 AM by Chelsey H
Pathfinder Tags: albumin blood genetics rice

Yet another use identified for this little resource! In addition to a delicious side dish and keeping pens from going bad, scientists have been able to use rice to make albumin, a protein found in human blood.

Rice grains. Image Credit: kidcyber

The demand for albumin is about 500 tons per year worldwide, and China has faced worrying shortages in the past such as in 2007 when the shortage led to price spikes and a brief rise in the number of fraudulent albumin medicines on the market. Currently, albumin is extracted from human blood donations which need thorough testing to prevent contamination and disease such as hepatitis and HIV.

The Science

Albumin is a generic term used for a type of protein which is water soluble. The protein can be found in many places in the natural world including egg whites and human blood plasma. In the human body, albumin is the most abundant protein in human blood plasma and is used to transport essential fatty acids from fat to muscle tissue. It also helps to regulate osmosis and the transport of hormones, drugs, and other substances through the blood. In medicine, is it used for treating burns, traumatic shock and liver disease.

Albumin Molecule. Image Credit: biowiki.edu-wiki.org

The Discovery

The study was completed by scientists at Wuhan University in China and colleagues from the National Research Council of Canada and the Center for Functional Genomic at the University at Albany in New York. The study was published in the scientific journal of the Proceedings of the National Academy of Sciences on October 31, 2011.

The scientists genetically engineered rice seeds to produce high levels of human serum albumin (HSA) by inserting human genes into Asian rice using bacteria. This turned the plants into biological "factories" that can produce proteins that are identical to those found in humans and worked out a way to purify the protein from the seeds. Over successive generations, the amount of HSA produced in the rice increased until it was 10% of the soluble protein produced in the rice. They were able to collect 2.75 grams of the protein per kilogram (2.2 pounds) of rice. When extracted from rice seeds, the protein is "physically and chemically equivalent to blood-derived human serum albumin (HSA)," said the research in the US-published Proceedings of the National Academy of Sciences.

The derivative was tested in rats with liver cirrhosis, a common condition for which the human equivalent is often used. Scientists found that it produced similar outcomes to treatment with HSA and no adverse reactions. "Our results suggest that a rice seed bioreactor produces cost-effective recombinant HSA that is safe and can help to satisfy an increasing worldwide demand for human serum albumin," said the study.

Albumin. Image Credit:mims.com

What's Next?

The "grown" HSA could be massed produced for use in hospitals, reducing the need to purify it from blood donations. The large-scale planting of genetically modified rice fields could produce enough seed for mass production of the protein, but it also raises environmental and food supply contamination concerns, since rice is a major world food staple.

However, the study authors noted that rice is a largely self-pollinating crop, pointing to previous studies that showed "a very low frequency (0.04-0.80%) of pollen-mediated gene flow between genetically modified (GM) rice and adjacent non-GM plants."

Dr Daichang Yang, the scientist who led the research at Wuhan University in central China, said: "The use of a rice seed bioreactor could provide an economical and safe approach for the production of non-animal derived compounds."

More research is needed to evaluate the safety of the rice-derived protein in animals and humans before it can be considered for the market.

Resources

What is Albumin?

Physorg.com

The Telegraph

Reply

Interested in this topic? By joining CR4 you can "subscribe" to
this discussion and receive notification when new comments are added.
Anonymous Poster #1
#1

Re: Blood Protein from Rice

11/10/2011 1:43 PM

While interesting, this may be putting the cart before the horse. Here and here are 2 published views separated in time by 6 years, yet both suggesting the lack of evidence supporting albumin therapy. Growing a strain of rice to harvest, it would be, specifically, for that purpose, it seems. I don't think it's a Holy Grail in medical research. The conclusion quoted below makes it seem like reinventing the wheel -- and a more Rube Goldberg path, at that. I certainly don't think it merits unleashing yet another GMO on the planet.

This abstract offers this Conclusion:

"For patients with hypovolaemia there is no evidence that albumin reduces mortality when compared with cheaper alternatives such as saline. There is no evidence that albumin reduces mortality in critically ill patients with burns and hypoalbuminaemia. The possibility that there may be highly selected populations of critically ill patients in which albumin may be indicated remains open to question. However, in view of the absence of evidence of a mortality benefit from albumin and the increased cost of albumin compared to alternatives such as saline, it would seem reasonable that albumin should only be used within the context of well concealed and adequately powered randomised controlled trial. PLAIN LANGUAGE SUMMARY: There is no evidence that giving human albumin to replace lost blood in critically ill or injured people improves survival when compared to giving saline. Trauma, burns or surgery can cause people to lose large amounts of blood. Fluid replacement, giving fluids intravenously (into a vein), is used to help restore blood volume and hopefully reduce the risk of dying. Blood products (including human albumin), non-blood products or combinations can be used. The review of trials found no evidence that albumin reduces the risk of dying. Albumin is very expensive in which case it may be better to use cheaper alternatives such as saline for fluid resuscitation."

Reply
Power-User

Join Date: Aug 2011
Posts: 272
Good Answers: 1
#2

Re: Blood Protein from Rice

11/21/2011 8:40 AM

Thank you for your comment. There have been many studies done that have both demonstrated and disproved the therapeutic benefits of albumin. And while it is currently a very expensive, hopefully this new discovery will reduce the cost of albumin as a therapy for the treatment of burns, volume replacement and management of liver disease. Albumin has been identified as a viable drug carrier for the treatment of tumors, and sepsis among having other benefits. It may not be a Holy Grail approach for the use albumin but the technology does open doors for the potential growth and production of other therapies.

__________________
“Everybody is a genius. But if you judge a fish by its ability to climb a tree, it will live its whole life believing that it is stupid.” Albert Einstein
Reply
Reply to Blog Entry 2 comments

Previous in Blog: Another Good Reason to Drink Red Wine   Next in Blog: Success In Regrowing Muscles From Pig Cells

Advertisement